CY1542A - Novel 8a-acylaminoergolines - Google Patents

Novel 8a-acylaminoergolines Download PDF

Info

Publication number
CY1542A
CY1542A CY1542A CY154291A CY1542A CY 1542 A CY1542 A CY 1542A CY 1542 A CY1542 A CY 1542A CY 154291 A CY154291 A CY 154291A CY 1542 A CY1542 A CY 1542A
Authority
CY
Cyprus
Prior art keywords
offormula
compound
acid addition
addition salt
phenyl
Prior art date
Application number
CY1542A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1542A publication Critical patent/CY1542A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY1542A 1984-01-12 1991-03-22 Novel 8a-acylaminoergolines CY1542A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3400853 1984-01-12

Publications (1)

Publication Number Publication Date
CY1542A true CY1542A (en) 1991-03-22

Family

ID=6224786

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1542A CY1542A (en) 1984-01-12 1991-03-22 Novel 8a-acylaminoergolines

Country Status (28)

Country Link
US (2) US4950672A (OSRAM)
JP (1) JPH0655739B2 (OSRAM)
AT (1) AT391317B (OSRAM)
AU (3) AU583489B2 (OSRAM)
BE (1) BE901456A (OSRAM)
CA (1) CA1245640A (OSRAM)
CH (1) CH664568A5 (OSRAM)
CY (1) CY1542A (OSRAM)
DE (1) DE3500251C2 (OSRAM)
DK (1) DK169891B1 (OSRAM)
ES (1) ES8605514A1 (OSRAM)
FI (1) FI82466C (OSRAM)
FR (1) FR2560196B1 (OSRAM)
GB (1) GB2152507B (OSRAM)
GR (1) GR850065B (OSRAM)
HK (1) HK48590A (OSRAM)
HU (1) HU197569B (OSRAM)
IE (1) IE58228B1 (OSRAM)
IL (1) IL74043A (OSRAM)
IT (1) IT1214648B (OSRAM)
LU (1) LU85725A1 (OSRAM)
NL (1) NL193541C (OSRAM)
NZ (1) NZ210818A (OSRAM)
PH (1) PH23286A (OSRAM)
PT (1) PT79818B (OSRAM)
SE (1) SE460420B (OSRAM)
SG (1) SG32390G (OSRAM)
ZA (1) ZA85276B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
ATE107647T1 (de) * 1984-04-09 1994-07-15 Schering Ag 2-substituierte ergolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
NL8700046A (nl) * 1986-01-24 1987-08-17 Sandoz Ag 8 alfa-acylaminoergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
US4931447A (en) * 1987-06-15 1990-06-05 Eli Lilly And Company Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
US4981859A (en) * 1987-06-15 1991-01-01 Cycloalkylamides of (8 beta )-1-alkyl-6-(substituted)ergolines
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto
DE3820159A1 (de) * 1987-06-23 1989-01-05 Sandoz Ag 8(alpha)-acylaminoergolin, seine herstellung und dieses enthaltende arzneimittel
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
GB8824744D0 (en) * 1988-10-21 1988-11-30 Erba Carlo Spa Antiemesis ergoline derivatives
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
CA2974113A1 (en) 2015-01-20 2016-07-28 Xoc Pharmaceuticals, Inc. Isoergoline compounds and uses thereof
BR112017015487A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
CA3064274A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218323A (en) * 1965-11-16 Esters of i,g-dimethyl-b-ergolenyl carbamic acid
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
CH622519A5 (en) * 1974-07-05 1981-04-15 Hoechst Ag Process for the preparation of hydroxyalkylxanthines
US4348392A (en) * 1974-07-19 1982-09-07 Sandoz Ltd. 8α-Substituted ergoline-I derivatives
GB1517973A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
CH622518A5 (en) * 1976-12-14 1981-04-15 Sandoz Ag Process for the preparation of novel ergoline compounds
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
HU195810B (en) * 1984-12-24 1988-07-28 Sandoz Ag Process for preparing new 8alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing such compounds
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto

Also Published As

Publication number Publication date
GB8500454D0 (en) 1985-02-13
GB2152507B (en) 1987-07-15
AU618290B2 (en) 1991-12-19
HUT37148A (en) 1985-11-28
AT391317B (de) 1990-09-25
SE460420B (sv) 1989-10-09
GR850065B (OSRAM) 1985-05-03
AU609539B2 (en) 1991-05-02
ZA85276B (en) 1986-08-27
IL74043A0 (en) 1985-04-30
AU3760985A (en) 1985-07-18
ES8605514A1 (es) 1986-03-16
FI850130L (fi) 1985-07-13
HK48590A (en) 1990-06-29
IE850064L (en) 1985-07-12
HU197569B (en) 1989-04-28
SE8500107D0 (sv) 1985-01-10
DK12685D0 (da) 1985-01-10
FI850130A0 (fi) 1985-01-11
JPH0655739B2 (ja) 1994-07-27
DE3500251A1 (de) 1985-07-18
FI82466C (fi) 1991-03-11
SG32390G (en) 1990-08-03
PT79818A (en) 1985-02-01
PT79818B (en) 1987-01-07
IT1214648B (it) 1990-01-18
IE58228B1 (en) 1993-08-11
DK169891B1 (da) 1995-03-27
ATA5985A (de) 1990-03-15
FR2560196A1 (fr) 1985-08-30
NL8500008A (nl) 1985-08-01
DK12685A (da) 1985-07-13
IT8547538A0 (it) 1985-01-11
FI82466B (fi) 1990-11-30
GB2152507A (en) 1985-08-07
AU583489B2 (en) 1989-05-04
CA1245640A (en) 1988-11-29
NL193541B (nl) 1999-09-01
PH23286A (en) 1989-06-30
FR2560196B1 (fr) 1986-07-18
ES539511A0 (es) 1986-03-16
US5077298A (en) 1991-12-31
DE3500251C2 (de) 1995-01-26
AU2506788A (en) 1989-03-02
JPS60174783A (ja) 1985-09-09
SE8500107L (sv) 1985-07-13
AU2506688A (en) 1989-02-23
IL74043A (en) 1988-10-31
US4950672A (en) 1990-08-21
CH664568A5 (de) 1988-03-15
LU85725A1 (fr) 1985-10-22
NZ210818A (en) 1989-02-24
NL193541C (nl) 2000-01-04
BE901456A (fr) 1985-07-08

Similar Documents

Publication Publication Date Title
CY1542A (en) Novel 8a-acylaminoergolines
PL102353B1 (pl) A method of producing new derivatives of 1,1-diaminoethylene
EP0126968A1 (en) Ergoline derivatives, processes for their preparation and pharmaceutical compositions containing same
US4238486A (en) Indolobenzoxazines
AU635099B2 (en) Quinazoline derivatives and their preparation
EP0009655B1 (en) 6-amino substituted n-pyrrolyl-3-pyridazine amines, their preparation, and pharmaceutically antihypertensive compositions containing them
US4238490A (en) Antihypertensive pyridazin(2H)-3-ones
US4180581A (en) N-9,10-dihydrolysergyl-m-aminobenzoic acid amide derivative
US4791115A (en) 2,6-dimethyl-8α-pivaloylamino-9,10-didehydro-ergoline
US4183932A (en) Fused quinazolinones and preparation thereof
US4229451A (en) Ergopeptine derivatives
PL134179B1 (en) Process for preparing 8-alpha-derivatives of ergoline from 8-beta-derivatives of ergoline by means of isomerization
IE42372B1 (en) Ergoline derivatives
US4333939A (en) Tetrahydropyridinyl-indoles
US4091099A (en) 6-Hydrocarbon-ergopeptines
CA1163267A (en) Isoxazolyl indolamines
US4105777A (en) Indoles
US5212178A (en) 8α-acylamino ergolines and use as pharmaceutical agents
US4246201A (en) Substituted N-(3-phenylthiopropyl)-3,3-diphenyl-propylamines possessing pharmacological activity
EP0882045B1 (en) Process for the preparation of granisetron
US4609657A (en) Ergot peptide alkaloid derivatives, processes for their preparation and pharmaceutical compositions containing them
US6127362A (en) 9,10-diazatricyclo[4,4,1,12,5 ] decane and 2,7-diazatricyclo [4,4,0,03,8 ] decane derivatives having analgesic activity
US4503053A (en) C-Homo-9-oxa-ergolines
IE45702B1 (en) New pyridobenzodiazepinones, processes for their preparation and pharmaceutical compositions containing them
EP0240986B1 (en) D-nor-7-ergoline derivatives, process for preparing them, pharmaceutical composition and use